UKHSA urges individuals from ethnic minority groups to get vaccinated
New data highlights the inequalities in emergency hospital rates and vaccinations
Read More
Tag: influenza
UKHSA launches campaign for flu and COVID-19 vaccines
The NHS has already delivered over 20 million winter vaccines this year
Read More
NIH clinical trial for universal influenza vaccine begins
The universal vaccine could protect people against more strains of flu
Read More
Open Orphan to commence influenza human challenge study
Candidate exhibits a novel mechanism of action and differs considerably from previously approved drugs
Read More
GSK, Vir look beyond COVID-19 to develop new therapies for flu and other respiratory viruses
New agreement builds on existing collaboration to develop therapies for coronaviruses
Read More
EU OK for Roche’s oral flu treatment Xofluza
Oral treatment approved to treat uncomplicated influenza and for post-exposure prophylaxis
Read More
Open Orphan announces £2.5m influenza challenge study contract
Company subsidiary hVIVO will conduct study with a US biotech
Read More
Xofluza effective as preventative flu medicine
Xofluza is the first and only one-dose oral medicine approved to treat flu in otherwise healthy patients.
Read More
Gilead licenses respiratory, herpes antiviral research programs from Novartis
The antivirus programs include investigational agents with the potential to treat human rhinovirus, influenza and herpes viruses.
Read More
Enesi and BARDA to co-develop flu vaccines
The public-private partnership aims to provide a cost-effective technological innovation.
Read More
Approval for Seqirus flu vaccine
Seqirus has announced European approval of its new cell-based quadrivalent influenza vaccine.
Read More
Blue Water Vaccines links with Oxford Uni for flu vaccine
Blue Water Vaccines has signed an option agreement with the UK’s University of Oxford to exclusively license the latter’s novel and potentially revolutionary universal flu vaccine.
Read More
- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
